Vidarbha News

Graves Disease Market: Industry Analysis, Pipeline, Drugs, Companies by DelveInsight | Novartis, Abbott Laboratories, GlaxoSmithKline, Merck, Pfizer and Many Others

 Breaking News
  • No posts were found

Graves Disease Market: Industry Analysis, Pipeline, Drugs, Companies by DelveInsight | Novartis, Abbott Laboratories, GlaxoSmithKline, Merck, Pfizer and Many Others

May 21
22:01 2021
Graves Disease Market: Industry Analysis, Pipeline, Drugs, Companies by DelveInsight | Novartis, Abbott Laboratories, GlaxoSmithKline, Merck, Pfizer and Many Others

Graves Disease Market

DelveInsight’s “Graves’ Disease Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Graves’ Disease, historical and forecasted epidemiology as well as the Graves’ Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Some facts of Graves’ Disease Market Report:

  • According to National Institute of Diabetes and Digestive and Kidney Diseases (n.d.), the disease affects about 1 in 200 people in the United States and is the most common cause of hyperthyroidism.
  • According to an article by Wemeau et al. (2018), of 1,572 hyperthyroid patients living in France, 73.3% had Graves’ disease (either primary or recurrence), of whom 85% were female, with a mean age of 43 years (primary onset) to 44 years (recurrence).
  • The National Institute of Diabetes and Digestive and Kidney Diseases (n.d.), estimates that 30 percent of people who develop Graves’ disease will get a mild case of Graves’ ophthalmopathy. Up to 5 percent will get severe Graves’ ophthalmopathy.
  • As per American Thyroid Association (n.d.), the Graves’ Disease is 7-8 times more common in women than men.
  • According to Cleveland Clinic (n.d.), Graves’ disease affects one out of every 200 Americans, making it the top cause of hyperthyroidism.

 

Request for free sample report: https://www.delveinsight.com/sample-request/graves-disease-market

 

Some of Graves’ Disease Companies are:

  • Novartis
  • Abbott Laboratories
  • GlaxoSmithKline
  • Merck & Co., Inc
  • Pfizer, Inc.
  • RLC LABS
  • AbbVie, Inc.
  • Mylan N.V.
  • Allergan, plc
  • And Many Others

 

Request for free sample report: https://www.delveinsight.com/sample-request/graves-disease-market

 

Graves’ Disease is a common form of hyperthyroidism. In this autoimmune disease, the immune system creates antibodies known as thyroid-stimulating immunoglobulins. They then attach to healthy thyroid cells thus, causing one’s thyroid to create too much thyroid hormone.

Thyroid hormones affects various aspects of nervous system function, brain development, body temperature and other important elements. If left untreated, it causes weight loss, anxiety, jitteriness, irritability, depression, and mental or physical fatigue. Apart from these, other complications include eye problems, heart problems, skin problems etc.

Hand tremors, weight loss, rapid heart rate, intolerance to heat, fatigue, nervousness, irritability, muscle weakness, goiter, difficult sleeping and frequent formed bowel movements are some of the symptoms shared by individuals affected with Graves’ disease and hyperthyroidism.

 

Some of Graves’ Disease Therapies are:

  • Iscalimab
  • Secukinumab
  • And Many Others

 

Request for free sample report: https://www.delveinsight.com/sample-request/graves-disease-market

 

Scope of Graves’ Disease Report:

  • The report covers the descriptive overview of Graves’ Disease, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Graves’ Disease epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Graves’ Disease are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Graves’ Disease market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Graves’ Disease market

 

Table of Contents:

1. Key Insights

2. Executive Summary of Graves’ Disease

3. Competitive Intelligence Analysis for Graves’ Disease

4. Graves’ Disease: Market Overview at a Glance

5. Graves’ Disease: Disease Background and Overview

6. Patient Journey

7. Graves’ Disease Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Graves’ Disease Treatment

11. Marketed Products

List to be continued in report

12. Emerging Therapies

List to be continued in report

13. Graves’ Disease: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Graves’ Disease

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

Request for detailed TOC: https://www.delveinsight.com/sample-request/graves-disease-market

 

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/graves-disease-market